Skip to content

Evaluation of IMOD effect on oral lichen planus

Evaluation of IMOD effect on oral lichen planus

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138710291559N1
Enrollment
60
Registered
2010-01-09
Start date
2008-03-05
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lichen planus.

Interventions

IMOD 400 mg daily for 3 months.
Treatment - Drugs
IMOD 400 mg daily for 3 months

Sponsors

Research center of dental Science of Tehran University of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criteria: clinical histopathologic diagnosis of lichen planus (Lichen planus diagnosis will be made with clinical criteria, consisting of the presence of symmetric reticular or papular lesions with or without erosive/atrophic or Bullous components. Histopathologic features of oral lichen palnus are: 1) Areas of hyperparakeratosis or hyperorthokeratosis, often with a thickening of the granular cell layer and a saw-toothed appearance to the retepages. 2) Liquefaction degeneration or necrosis of the basal layer. 3) A dense subepithelial band, shaped by infiltration of lymphocytes and macrophages. 4) Absence of dysplastic changes) Exclusion criteria: Any systemic disease, pregnancy and any other mucosal lesions

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Clinical score. Timepoint: 2 weekly in the first month and then monthly for 6 months. Method of measurement: regesteration the primary scores of lesions and their changes on the follow up period as described in the matherial and methods.

Secondary

MeasureTime frame
Pain and discomfort in the oral lesion. Timepoint: 2 weekly in the first month and then monthly up to 6 month. Method of measurement: VAS scale as described in the matherial and method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Neda Akbary Gillani

Oral Medicine Department of Tehran University of Medical Siences

nedaakbary@gmail .com+98 21 2232 2825

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026